跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAPROSYN 500 naproxen 500 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
NAPROSYN 500 naproxen 500 mg tablet blister pack
Approved
STANDARD
NAPROSYN 500 naproxen 500 mg tablet blister pack
Atnahs Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0c100fbd3b0f8bef
Company
Atnahs Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
0c100fbd3b0f8bef
Product Name
NAPROSYN 500 naproxen 500 mg tablet blister pack
Artg Id
65246
Artg Name
NAPROSYN 500 naproxen 500 mg tablet blister pack
Sponsor
Atnahs Pharma Australia Pty Ltd
Company Detail Path
/organization/atnahs-pharma-australia-pty-ltd
Artg Date
1998-09-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a3ccbc6f42e642dff0d98025aaf4cd29.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c32ee855f3c375762351536678c9a2ca.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0c100fbd3b0f8bef
Type
Standard
Back to TGA Approvals